Full-Time

Medicare Appeals Coordinator

Posted on 8/19/2026

Mass General Brigham

Mass General Brigham

1-10 employees

Early-stage life science venture investor

Compensation Overview

$30.60 - $44.51/hr

+ Differentials + Premiums + Bonuses

Somerville, MA, USA

Remote

Remote from most US states; core hours are between 8:00 AM and 6:00 PM Eastern Time. Occasional Saturday coverage is required.

Bachelor's

Category
Legal & Compliance (1)
Required Skills
Customer Service

Get referred to Mass General Brigham

See people who can refer or advise you

Requirements
  • At least 3-5 years of health plan experience, ideally within customer service, quality, or appeals and grievances areas.
  • Detailed knowledge of applicable health plan policies and procedures.
  • Knowledge and expertise in regulatory requirements from the Centers for Medicare & Medicaid Services, Department of Insurance, and MassHealth, as well as contractual requirements.
  • Strong aptitude for technology-based solutions.
  • Strong customer service skills.
  • Strong interpersonal skills when interacting with customers, providers, and external agencies.
  • Excellent communication skills.
  • Ability to adapt to changing priorities and work effectively in a dynamic environment.
  • Excellent organizational abilities to manage multiple tasks, prioritize work, and meet deadlines.
  • Ability to function effectively in a remote environment while handling time-critical appeals and grievance cases.
Responsibilities
  • Handle a large volume of formal and informal incoming appeals from receipt through resolution, ensuring grievances are resolved within contractual and regulatory timeframes.
  • Document and supervise grievances in the appropriate tracking systems while maintaining high quality and accuracy.
  • Ensure grievance files are complete and contain research materials, acknowledgment and resolution letters, and other pertinent case documentation.
  • Collaborate with Compliance, Pharmacy, Medical Directors, Sales, and other relevant senior and executive staff on grievances.
  • Assist with or lead external appeal investigations from regulatory agencies, including the Centers for Medicare & Medicaid Services, EOHHS, and the Division of Insurance.
  • Assist with preparing formal written responses to external regulators.
  • Work independently with members on grievances and provide effective, appropriate information while resolving their issues.
  • Aid in preparing reports for collaborators and provide feedback to improve reporting.
  • Monitor changes to health plan policies and procedures and work with partners to ensure files prepared for external agencies are accurate, well-written, and meet stakeholder needs.
  • Participate in team meetings, development work, internal audits, and external audits.
  • Review inboxes and triage urgent requests during occasional Saturday coverage.
  • Perform other assigned duties with or without accommodation.
Desired Qualifications
  • Experience leading appeals and grievances for Medicare products and plans.
  • Bachelor's Degree.
  • Bilingual ability.

Mass General Brigham Ventures funds early-stage life science ideas arising from Mass General Brigham’s research network. It provides first access to deal flow and proprietary rights, backing the formation and growth of new companies and technologies. It uses capital and support to help translate bold innovations into drugs and medical technologies that improve patient outcomes worldwide.

Company Size

1-10

Company Stage

N/A

Total Funding

$1.9B

Headquarters

Cambridge, Massachusetts

Founded

2008

Get referred to Mass General Brigham

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Fiscal 2025 operating income reached $59 million after a $53 million reorganization charge.
  • Mead Johnson expanded a five-year research partnership with MGB in April 2026.
  • MGB bridge funding keeps NIH-dependent researchers alive through August 2026 deadlines.

What critics are saying

  • Brigham nurses struck July 2026 after a five-day lockout over wages and insurance.
  • MGB closed the Weiner Center, Burn Unit, and iCMP, angering clinicians.
  • Repeated labor conflict and service cuts threaten talent retention and patient trust.

What makes Mass General Brigham unique

  • Mass General Brigham runs nearly $2 billion in research and 3,700 trials.
  • Its 2026 MIT seed program linked 17 translational teams across engineering and care.
  • MGB controls first-look access to discoveries from Harvard-affiliated hospitals and investigators.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Flexible Work Hours

Remote Work Options

Hybrid Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Family Planning Benefits

Fertility Treatment Support

Professional Development Budget

Conference Attendance Budget

Wellness Program

Mental Health Support

Gym Membership

Phone/Internet Stipend

Home Office Stipend

Stock Options

Company Equity

401(k) Company Match

Parental Leave

Adoption Assistance

Childcare Support

Relocation Assistance

Employee Referral Bonus

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Meal Benefits

Commuter Benefits

Legal Services

Employee Discounts

Company Social Events

Company News

Claris Bio
Jul 29th, 2026
07-28-2026 Press Releases from Claris Bio

Latest Press Releases from Claris Bio.

Fierce Healthcare
Jun 15th, 2026
InStride Health lands $30M series C to expand pediatric mental health services

InStride Health, a provider of virtual specialty mental healthcare for children and young adults, has raised $30 million in Series C funding led by Echo Health Ventures and FMZ Ventures. Existing investors including .406 Ventures, General Catalyst and Mass General Brigham Ventures also participated. Founded in 2021, InStride offers insurance-based treatment for anxiety and obsessive-compulsive disorder in patients aged seven to 24. The company pairs each patient with a care team comprising a psychiatrist, therapist and exposure coach, providing support through text and a mobile application. InStride has treated 5,000 patients across 17 states, primarily on the East Coast and Texas. The company published data showing 97% of patients demonstrated clinical improvement, with a 53% average reduction in anxiety scores. The funding will support expansion into new markets and strengthen payer partnerships.

Associated Press
May 13th, 2026
Violet Therapeutics raises $4.75M to advance synaptic preservation therapy for neurodegenerative diseases

Violet Therapeutics, a biotechnology company developing therapies for neurodegenerative diseases, has raised $4.75 million in a seed extension round led by Lifespan Vision Ventures. Dementia Discovery Fund, UTEC, Ono Venture Investment and Mass General Brigham Ventures also participated. The Cambridge-based company will use the funding to advance its lead small molecule programme targeting EphB3 through IND-enabling activities. The therapy aims to halt and potentially reverse cognitive decline through glial-mediated synaptic preservation, addressing synaptic loss, the strongest predictor of cognitive decline in Alzheimer's and other neurodegenerative diseases. Violet's proprietary CONNECT platform maps cell-cell interaction networks to identify novel therapeutic targets. Founded by Mass General Brigham Ventures with researchers from Brigham and Women's Hospital, the company is developing first-in-class CNS therapies.

PR Newswire
Apr 23rd, 2026
Brigham nurses to picket as MGB executives earn $35.9M amid service closures and 0% wage offer

Registered nurses at Brigham and Women's Hospital will hold an informational picket on 29 April, protesting Mass General Brigham's corporate decisions affecting patient care and workforce conditions. The Massachusetts Nurses Association represents the nurses, who will demonstrate from 14:00 to 16:00 outside the hospital at 75 Francis Street, Boston. Nurses cite several service closures under MGB, including the Weiner Centre, Burn Unit and Integrated Care Management Programme. They criticise the health system's bargaining proposals, particularly a 0% wage offer for nurses below top step, whilst MGB reported a $59.2 million operating gain in 2025 and paid its top 14 executives $35.9 million in fiscal year 2024. The informational picket will not disrupt patient care, with nurses participating outside working hours.

PR Newswire
Mar 19th, 2026
MGB Home Care clinicians to picket Mass General over stalled contract talks after year of bargaining

Approximately 450 clinicians at Mass General Brigham Home Care, represented by the Massachusetts Nurses Association, will hold an informational picket on 24 March outside Massachusetts General Hospital. The clinicians are seeking their first union contract after more than 20 bargaining sessions since March 2025. The bargaining unit includes registered nurses, occupational therapists, physical therapists, speech language pathologists, social workers and dieticians who voted to join the MNA in June 2024. They are demanding reasonable caseload limits, clear productivity standards, competitive wages and recruitment protections. MGB reported a $59.2 million operating gain in the year ending September 2025, with CEO Dr Anne Klibanski's compensation rising 40% to $8.4 million in 2024. The picket is scheduled for 15:30 to 17:00 and is not a strike.